2023 Food and Drug Law Journal Symposium – Regulating on Shifting Sands: Analyzing the Impact of Recent and Upcoming Federal Court Decisions on FDA’s Authority
Event summary
The Food and Drug Law Institute’s 2023 Food and Drug Law Journal Symposium explored the evolving legal landscape and recent implications for the Food and Drug Administration’s regulatory authority. Scholars and seasoned practitioners focused on current and upcoming federal court decisions and their effects on the FDA. By examining pivotal cases brought before the federal bench, symposium participants examined the potentially far-reaching repercussions for FDA operations.
Featured agenda item
Wednesday, November 8, 2023 | 10:10 – 11:25 am
Orphan Drug Exclusivity: A Review of Key Case Law and Themes in FDA’s Interpretation of ODD and ODE
Speaker:
- Sonia Nath – Partner at Cooley
For more information, please email Rebecca Lanz.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.